Dr. Miran Joel Blanchard, MD

Dr. Blanchard practices at Sanford Bemidji Medical Center in Bemidji, Minnesota, part of Sanford Health.

Dr. Blanchard's NPI, 1629369830, was assigned on April 21, 2011. Dr. Blanchard graduated from University of North Dakota School of Medicine in 2010. Dr. Blanchard holds North Dakota license 13647.

Dr. Blanchard's primary practice is Sanford Bemidji Medical Center, at 1300 Anne St NW, Bemidji, MN 56601 in Beltrami County. The practice phone is (218) 751-5430.

Dr. Blanchard's primary practice is Sanford Bemidji Medical Center in Bemidji, Minnesota, part of Sanford Health. Dr. Blanchard is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Blanchard to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Blanchard practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Blanchard's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Blanchard's licenses on file in 2 states: North Dakota and Minnesota.

CMS data shows 2,054 Medicare services from Dr. Blanchard across 17 procedure codes in 2024, for 137 Medicare patients. Medicare paid $139,417 for them.

CMS counts 137 Medicare patients who saw Dr. Blanchard in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have cancer, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 2.19, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Blanchard's median patient age at 74, with 29% women.

In 2024, Dr. Blanchard wrote 464 Medicare Part D claims for 172 patients. 92% of them were for generic drugs. CMS names the drug for 356 of them, across 12 drugs with 11 or more claims each, at $8,399 in total drug cost. In 2023, CMS named 492 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Blanchard for performance year 2024, reported as part of a group. Dr. Blanchard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Blanchard as offering telehealth.

Dmand AI links 12 papers to Dr. Blanchard, published from 2013 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Radiotherapy Dosage. Dr. Blanchard's most frequent co-authors are Nadia Nicole Issa Laack, MD, Robert L. Foote, MD and Ryan Kevin Funk, MD.

Dmand AI links Dr. Blanchard to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Oropharyngeal Neoplasms and Pharyngeal Neoplasms.

CMS Open Payments shows 2 general payments to Dr. Blanchard from 2 drug and device companies from 2019 to 2022. Food and beverage make up the largest share, 100% of the total. Blue Earth Diagnostics Limited paid the most, $73.

Dr. Blanchard graduated from University of North Dakota School of Medicine in 2010.